Abrexa Pharmaceuticals, Inc. — Form D/A
Abrexa Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2019-02-07. The offering totals $16.6M, of which $16.6M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-02-07
- Form: D/A
- Accession: 0001529349-19-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $16.6M
- Amount sold: $16.6M
- Investors: 7
- Date of first sale: 2018-07-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-318790
Issuer
- Name: Abrexa Pharmaceuticals, Inc.
- CIK: 0001529349
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 402 W Broadway, SAN DIEGO, CA, 92101
- Phone: (619) 295-5077
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| David J Hugley | Director | San Diego, CA |
| David J Hughley | Director | San Diego, CA |
| James J Truchard | Director | San Diego, CA |
| J. Ernest Villafranca | Director | San Diego, CA |
| J. Ernest Villafranca | Executive Officer | San Diego, CA |
| Eckard Weber, M.D. | Director | Menlo Park, CA |
| Eckard Weber, M.D. | Executive Officer | Menlo Park, CA |
| Nicole Vitullo | Director | Atlanta, GA |
| Lynne Rollins | Executive Officer | Los Angeles, CA |
Other filings by this issuer (3)
More